PMV Pharma Q2 EPS $(0.38) Beats $(0.47) Estimate
Portfolio Pulse from Benzinga Newsdesk
PMV Pharma (NASDAQ:PMVP) reported Q2 losses of $(0.38) per share, beating the analyst consensus estimate of $(0.47) by 19.15 percent. This is unchanged from the same period last year.
August 09, 2023 | 12:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
PMV Pharma's Q2 losses per share were less than expected, which could be seen as a positive sign by investors.
PMV Pharma reported lower than expected losses for Q2, which could be interpreted as a positive sign by investors. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100